Found: 9
Select item for more details and to access through your institution.
Acknowledgement to Referees.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 4, p. 251, doi. 10.1007/s40268-018-0252-x
- Publication type:
- Article
Isavuconazole Kinetic Exploration for Clinical Practice.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 4, p. 317, doi. 10.1007/s40268-018-0251-y
- By:
- Publication type:
- Article
Two Glucose-Lowering Mechanisms of Canagliflozin Depending on Body Weight Changes in Drug-Naïve Subjects with Type 2 Diabetes.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 4, p. 309, doi. 10.1007/s40268-018-0250-z
- By:
- Publication type:
- Article
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
- Published in:
- Drugs in R&D, 2018, v. 18, n. 4, p. 271, doi. 10.1007/s40268-018-0254-8
- By:
- Publication type:
- Article
Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 4, p. 259, doi. 10.1007/s40268-018-0253-9
- By:
- Publication type:
- Article
Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 4, p. 283, doi. 10.1007/s40268-018-0255-7
- By:
- Publication type:
- Article
Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 4, p. 303, doi. 10.1007/s40268-018-0249-5
- By:
- Publication type:
- Article
Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 4, p. 255, doi. 10.1007/s40268-018-0247-7
- By:
- Publication type:
- Article
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 4, p. 295, doi. 10.1007/s40268-018-0248-6
- By:
- Publication type:
- Article